Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biometrical Journal. Biometrische Zeitschrift|December 9, 2022
Deep transformation models for functional outcome prediction after acute ischemic strokeLisa Herzog, Lucas Kook, Andrea Götschi, et al.
RMD Open|June 5, 2023
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registryAdrian Ciurea, Andrea Götschi, Seraphina Kissling, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 1, 2023
Long-term neurodevelopmental outcome and serial cerebral magnetic resonance imaging assessment in Fontan patients at school ageBettina Reich, Sabrina Schwan, Kristina Heye, et al.
The Cochrane Database of Systematic Reviews|September 8, 2023
Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosisKelly Reeve, Begum Irmak On, Joachim Havla, et al.
Clinical and Experimental Rheumatology|June 29, 2026
Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparisonMarlene Stirnimann-Agustoni, Julia-Tatjana Maul, Enriqueta Vallejo-Yagüe, et al.
RMD Open|December 6, 2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registryAdrian Ciurea, Andrea Götschi, René Bräm, et al.
RMD Open|July 28, 2023
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 yearsCaroline Ensslin, Raphael Micheroli, Seraphina Kissling, et al.
Clinical Rheumatology|March 10, 2025
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohortAnnik Steimer, Andrea Götschi, Torsten Witte, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Pageof 2